Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 84 of 102, showing 5 Applications out of 508 total, starting on record 416, ending on 420

# Protocol No Study Title Investigator(s) & Site(s)

416.

ECCT/15/04/02  
    Plasma concentration profiles after oral  administration of oleylphosphocholine tablet  formulation: safety, tolerability and pharmacokinetics  of 100 mg single dose in healthy male volunteers.   
Principal Investigator(s)
1. Ravasco Rashid Juma
Site(s) in Kenya
KEMRI
 
View

417.

ECCT/15/03/01   A phase III, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering
    A phase III, randomized, double-blind, active, controlled, multinational, multicentre,  non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally.   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
Kenyatta National Hospital
 
View

418.

ECCT/15/02/05  
    An open-label clinical trial to assess the pharmacokinetics and safety of miltefosine allometric dose for the treatment of children with primary visceral leishmaniasis in Eastern Africa   
Principal Investigator(s)
1. Rashid Juma
Site(s) in Kenya
1. Kimalel Health Centre (Baringo county)
2. Kacheliba District Hospital (West Pokot county)
 
View

419.

ECCT/15/02/03   IVERMAL study
    Efficacy and safety of high-dose Ivermectin for reducing malaria transmission: A dose finding study   
Principal Investigator(s)
1. Menno Roderick Smit
Site(s) in Kenya
1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) (Kisumu county)
2. Kisumu District Hospital (KDH), (Kisumu county)
3. Siaya District Hospital (Siaya county)
4. Vihiga District Hospital (Vihiga county)
 
View

420.

ECCT/15/01/05   In vivo efficacies of AL and DP
    Open label randomized study evaluating the in vivo efficacies of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in children under five years of age in western Kenya.   
Principal Investigator(s)
1. AAron Samuels
2. Simon Kariuki
Site(s) in Kenya
Siaya District Hospital
 
View